Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Obseva Sa
(NQ:
OBSV
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 22, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Obseva Sa
< Previous
1
2
3
4
5
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 22, 2022
With the long weekend over it's time to start another week of trading with the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
30 Stocks Moving in Tuesday's Pre-Market Session
February 22, 2022
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) rose 28.5% to $108.31 in pre-market trading. Just hours after launching on Sunday night in Apple’s App Store, Donald...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 14, 2022
During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks Noteable 52-Week Lows And Highs: SAP (...
Via
Benzinga
ObsEva Expects Delay In Linzagolix Application Submission In Europe For Uterine Fibroids
February 07, 2022
ObsEva SA (NASDAQ: OBSV) said that based on ongoing communications with the European Medicines Agency (EMA), it expects further questions on the linzagolix application, thereby
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 01, 2022
Rise and shine, trader! We're starting off another day of investing with a breakdown of the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
16 Stocks Moving in Tuesday's Pre-Market Session
February 01, 2022
Gainers ObsEva SA (NASDAQ: OBSV) rose 22.2% to $1.87 in pre-market trading after the company announced a corporate update, including an increase in share capital on...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 31, 2022
Welcome back, trader! We're ready for another busy week of trading as we start it with the biggest pre-market stock movers for Monday!
Via
InvestorPlace
18 Stocks Moving in Monday's Pre-Market Session
January 31, 2022
Gainers FGI Industries Ltd. (NASDAQ: FGI) rose 92.8% to $7.27 in pre-market trading after jumping 19% on Friday. The company, last week, priced its IPO at $6 per...
Via
Benzinga
7 Penny Stocks to Buy for January
January 10, 2022
These penny stocks look poised for a rally in January 2022 and can possibly deliver multi-fold returns in the next 12 months.
Via
InvestorPlace
33 Stocks Moving In Thursday's Mid-Day Session
January 06, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe...
Via
Benzinga
The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales
January 06, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 06, 2022
Good morning, trader! Let's start off the day right with a look into some of the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
23 Stocks Moving in Thursday's Pre-Market Session
January 06, 2022
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 54.3% to $0.9490 in pre-market trading after declining more than 11% on Wednesday. Alterity Therapeutics Limited...
Via
Benzinga
7 of the Best Penny Stocks Under $3 for 2022 to Buy Now
December 31, 2021
Penny stocks under $3 are full of potential and potential pitfalls. These are relatively safe and worth your consideration.
Via
InvestorPlace
Why Are ObsEva Shares Trading Higher Today?
December 17, 2021
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval for ObsEva SA'...
Via
Benzinga
28 Stocks Moving In Friday's Mid-Day Session
December 17, 2021
Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. X4 Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
December 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 17, 2021
Good morning, investor! We're in the home stretch of the week as we tackle the biggest pre-market stock movers for Friday!
Via
InvestorPlace
20 Stocks Moving in Friday's Pre-Market Session
December 17, 2021
Gainers Genfit SA (NASDAQ: GNFT) rose 47.5% to $4.90 in pre-market trading. Ipsen and GENFIT reported an exclusive licensing agreement for Elafibranor. Spruce Biosciences, Inc. (...
Via
Benzinga
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
December 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Angion Biomedica's ANG-3777 Does Not Meet Primary Endpoint In Mid-Stage...
Via
Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...
Via
Benzinga
Exposures
Product Safety
10 Biggest Price Target Changes For Monday
November 29, 2021
Citigroup cut Merck & Co., Inc. (NYSE: MRK) price target from $105 to $85. Merck shares fell 2% to $77.55 in pre-market trading. Keybanc lowered Arista Networks, Inc. (...
Via
Benzinga
7 Hot Penny Stocks to Buy for December That Are Positioned to Pop
November 24, 2021
These penny stocks remain positioned to run upwards in the near term. Purchasing shares in December could quickly lead to profits.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 22, 2021
Welcome back, traders! We're getting right into the week with a breakdown of the biggest pre-market stock movers for Monday!
Via
InvestorPlace
Exposures
Product Safety
20 Stocks Moving in Monday's Pre-Market Session
November 22, 2021
Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per...
Via
Benzinga
ObsEva Shares Jump After Linzagolix Application For Uterine Fibroids Goes Under FDA Review
November 22, 2021
The FDA has accepted for review ObsEva SA's (NASDAQ: OBSV) marketing application for linzagolix to manage heavy menstrual bleeding associated with uterine...
Via
Benzinga
Exposures
Product Safety
7 Penny Stocks to Book Profits on Before 2022
November 16, 2021
Penny stocks can turn a quick profit. These 7 picks are designed to do so before the end of this year and cover multiple sectors.
Via
InvestorPlace
24 Stocks Moving in Thursday's Pre-Market Session
November 04, 2021
Gainers Evaxion Biotech A/S (NASDAQ: EVAX) rose 143.5% to $15.83 in pre-market trading after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) rose 72.6% to $4.09...
Via
Benzinga
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
October 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Novavax Shares React to Reports Of Manufacturing Issues With Its COVID-19...
Via
Benzinga
ObsEva Presents Linzagolix Data From Uterine Fibroid Trials
October 20, 2021
ObsEva SA (NASDAQ: OBSV) has announced data from PRIMROSE (1 and 2) Phase 3 study of linzagolix for uterine fibroids. The data were presented at the American...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.